Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today, it made a strategic investment in Stratos Genomics and entered into a research collaboration to support further development of their unique chemistry applied to single molecule sequencing of DNA fragments using protein nanopores.
Seattle, Washington—February 20, 2013 – Stratos Genomics Inc today announced that it has reached its next significant milestone by achieving single molecule DNA sequencing of 100+ base templates with its patented “Sequencing by Expansion™” (SBX) technology. Stratos Genomics also announced the addition of Tim Hunkapiller, co-inventor of four-color Sanger sequencing, to its Science Advisory Board (SAB).
SEATTLE, WA—(Marketwire – Oct 9, 2012) – Stratos Genomics Inc today announced the closing of $2 million to support continued development and strategic discussions related to Stratos’ ultra low cost method of DNA sequencing called “Sequencing by Expansion™” (SBX™).
The funding follows the successful demonstration of single molecule DNA sequencing of 36 base templates by SBX this past June.
Seattle, Wash. – August 23, 2011 – Stratos Genomics Inc. today announced receipt of grant funds from the National Human Genome Research Institute in the amount of $829,000 over two years. The NHGRI, part of the National Institutes of Health (NIH), awarded $14 million to nine qualifying research organizations on Monday, August 22, 2011, to support the development of revolutionary DNA sequencing technologies.
Seattle, Wash. – June 8, 2011 – Stratos Genomics Inc today announced $2.1 million of funding to continue development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics. The funds are provided by existing shareholders as an “up round” to August 2010’s $4 million financing and under the same Series-A terms.
Seattle, Wash. – May 25, 2011 – Stratos Genomics Inc today announced it has been granted US Patent 7,939,259 titled “High Throughput Nucleic Acid Sequencing by Expansion.” Sequencing by Expansion™ (SBX™) is a method for converting DNA into a more easily-read polymer called an Xpandomer™. Xpandomers encode DNA base sequence information with high signal-to-noise reporters optimally positioned along the polymer chain. SBX is a solution to the intrinsic problem of sequencing native DNA at high-speed and low cost.
Seattle, Wash. – September 7, 2010 – Stratos Genomics Inc. today announced it has closed a Series-A financing deal of $4 million to continue development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics. The round was led by Fisk Ventures and included Stratos Group LLC.